Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Respiri Limited ( (AU:RSH) ) has issued an announcement.
Respiri Limited announced the retirement of Dr. Tom Takubo from its Board of Directors and the appointment of Jonathan Adams as a new Non-Executive Director. Adams, who brings extensive experience in U.S. capital and investment markets, is expected to strengthen Respiri’s US growth strategy and governance, enhancing shareholder value. His expertise, particularly in healthcare and investment, aligns with Respiri’s mission to revolutionize healthcare delivery, positioning the company for further expansion and integration of its innovative solutions.
More about Respiri Limited
Respiri Limited is a pioneering company in the healthcare industry, focusing on transforming healthcare delivery in the US through innovative medical devices and MedTech solutions. The company specializes in remote healthcare solutions, offering comprehensive Care Management programs for chronic conditions, including exclusive remote wheeze detection for respiratory disorders. By integrating advanced solutions into existing healthcare systems, Respiri aims to enhance efficiency and reduce overall healthcare costs.
YTD Price Performance: 4.00%
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $42.98M
For detailed information about RSH stock, go to TipRanks’ Stock Analysis page.
